The Oncology Institute Inc (NAS:TOI)
$ 0.4337 0.026 (6.27%) Market Cap: 32.28 Mil Enterprise Value: 86.29 Mil PE Ratio: 0 PB Ratio: 0.78 GF Score: 28/100

Oncology Institute Inc at UBS Global Healthcare Conference Transcript

May 24, 2022 / 02:00PM GMT
Release Date Price: $8.43 (-6.12%)
Andrew Mok
UBS Investment Bank, Research Division - Analyst

Hi. Good morning, and welcome back to the UBS Healthcare Conference. My name is Andrew Mok. I'm the health care providers analyst at UBS. And joining me on stage is CEO of the Oncology Institute. Brad, welcome to -- Brad Hively. Brad, welcome to the stage and welcome to the UBS Healthcare Conference.

Bradford D. Hively
The Oncology Institute, Inc. - CEO & Director

Thanks, Andrew. It's a pleasure to be here with you. I appreciate the invite and the interest.

Andrew Mok
UBS Investment Bank, Research Division - Analyst

Absolutely. And Brad, to start, why don't you give us a little bit of background on the company and help us understand how you're differentiated versus a traditional oncology practice.

Bradford D. Hively
The Oncology Institute, Inc. - CEO & Director

Yes, sure. So TOI is a large community oncology group, and we're the nation's leading value-based oncology group. So what that means is we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot